Colon cancer remains one of the most prevalent yet often undetected forms of cancer, developing silently in the large intestine. According to recent medical

A Houston mother was diagnosed with stage 4 colon cancer in 2021 after brushing off five subtle symptoms. Since then, she’s been raising awareness on TikTok.

If you aim to improve your diet and health in 2025, especially as we usher in the new year, you’ve come to the right place. In an informative TikTok video, Dr. Tim Tiutan, an oncology hospitalist, offered advice on weight loss that also reduces

To mark Cervical Cancer Prevention Week, a women's health expert has shared the five major symptoms you should look out for and why regular cervical screenings are so important

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of cancer and dementia,

SNUBBING Dry January and continuing to drink like it’s Christmas may seem like a great way to get through the dreary first month of the year. But long-term boozing can seriously damage the

LIVER cancer has become the UK’s fastest rising cause of cancer death with obesity, smoking and boozing behind higher cases, research has found. Cancer Research UK said the death rate has doubled

The 21-year-old rapper shared photos of her bruising and fired back at critics, clarifying that she was "cleared" by her doctor for the procedure

With the recent surge in popularity of weight loss drugs like Ozempic, altogether called GLP-1s, there has been renewed scientific interest in understanding how our bodies regulate muscle growth. Scientists have linked the protein BCL6 to the maintenance of muscle mass and further suggested that BCL6-boosting therapeutics could help GLP-1 users retain muscle while losing fat.

Part of that spike is due to rising rates of cancers that affect primarily women, including breast cancer and endometrial cancer (a.k.a. cancer in the lining of the uterus), Rebecca Siegel, MPH, senior scientific director of surveillance research at the American Cancer Society and the first author of the above report,

American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common diabetes drugs.